Sort
27,075 grants matching “cholesterol”
Tumor-Targeted Multimodality Nanoscale Coordination Polymers for Chemo-Immunotherapy of Metastatic Colorectal Cancer
$466,819Wenbin Lin · University Of Chicago · R01 · FY2023 · CA
Tumor-Targeted Multimodality Nanoscale Coordination Polymers for Chemo-Immunotherapy of Metastatic Colorectal Cancer
$466,819Ralph R Weichselbaum · University Of Chicago · R01 · FY2025 · CA
Project 2: Regulation of lipid and glucose metabolism by ANGPTL3 in humans
$466,793Nathan Oliver Stitziel · University Of Washington · P01 · FY2024 · HL
Fatty Acid Binding Protein in Atherosclerosis
$466,721Macrae F Linton · Vanderbilt University · R01 · FY2009 · HL
Characterization of Atherosclerosis Modifier Genes
$466,560Jonathan D Smith · Cleveland Clinic Lerner Com-Cwru · R01 · FY2012 · HL
Characterization of Atherosclerosis Modifier Genes
$466,502Jonathan D Smith · Cleveland Clinic Lerner Com-Cwru · R01 · FY2011 · HL
Defining genetic and metabolic requirements of aggressive breast cancer
$466,499Susan E Waltz · University Of Cincinnati · R01 · FY2023 · CA
Defining genetic and metabolic requirements of aggressive breast cancer
$466,496Susan E Waltz · University Of Cincinnati · R01 · FY2022 · CA
Cholesterol-dependent control of HIV progression by antigen presenting cells
$466,486Giovanna Rappocciolo · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AI
Modulation of Lipid Bisretinoids Clearance with Beta-Cyclodextrins
$466,458Marcelo M Nociari · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · EY
C-Kit in atherosclerosis
$466,401Roberto Irenardo Vazquez Padron · University Of Miami School Of Medicine · R01 · FY2018 · HL
Role of the microglial immune-oxysterol 25-hydroxycholesterol in mediating neuroinflammation and neurodegeneration in the P301S tau transgenic mouse model of Alzheimer's disease
$466,366Anil G Cashikar · Washington University · R01 · FY2024 · AG
Towards systematic analysis of cardiac voltage-gated sodium channel beta subunit function
$466,355Christopher A Ahern · University Of Iowa · R33 · FY2024 · HL
Aerobic Fitness, Mitochondrial Function, and Fatty Liver Disease.
$466,270John P Thyfault · University Of Kansas Medical Center · R01 · FY2020 · DK
Genetic Engineering of Vein Bypass Grafts in Vascular and Cardiovascular Surgery
$466,268Frank W Logerfo · Beth Israel Deaconess Medical Center · R01 · FY2014 · HL
Uncovering Dementia-Related Lipid Alterations and Mechanisms in Astrocytes
$466,125Anna Goldshmidt Orr · Weill Medical Coll Of Cornell Univ · R21 · FY2024 · AG
Aerobic Fitness, Mitochondrial Function, and Fatty Liver Disease.
$465,985John P Thyfault · University Of Kansas Medical Center · R01 · FY2021 · DK
A Phase 1 Dose Escalation Study of Vorinostat in Niemann-Pick C1 Disease
$465,978Daniel S Ory · Washington University · U01 · FY2015 · HD
Pathways of Oxidation of HDL by Macrophages
$465,921Jay W Heinecke · University Of Washington · P01 · FY2009 · HL
Effects of Aging on Experimental Atherosclerosis in Nonhuman Primates
$465,919Edward Lakatta · National Institute On Aging · ZIA · FY2017 · AG
Age-Associated Changes in Arterial Proteome and Aortic Smooth Muscle Signaling
$465,919Edward Lakatta · National Institute On Aging · ZIA · FY2017 · AG
Genetic Epidemiology of Diabetic Complications
$465,902Robert Hanson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
ATHEROSCLEROSIS AND PERIPHERAL APOPROTEIN E SYNTHESIS
$465,743State University New York Stony Brook · R01 · FY2000 · HL
Characterization of Atherosclerosis Modifier Genes
$465,718Jonathan D Smith · Cleveland Clinic Lerner Com-Cwru · R01 · FY2010 · HL
HDL receptor SR-BI and a model of coronary heart disease
$465,679Massachusetts Institute Of Technology · P01 · FY2005 · HL